A. Di Cerbo

Comparison between an Emerging Point-of-Care Tool for TSH Evaluation and a Centralized Laboratory-Based Method in a Cohort of Patients from Southern Italy

A. Napolitano, A. di Cerbo, F. Pezzuto, 2021, Diagnostics.

Skeletal Involvement in Female Acromegalic Subjects: The Effects of Growth Hormone Excess in Amenorrheal and Menstruating Patients

I. Chiodini, A. Scillitani, A. Liuzzi, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Combined 17α-Hydroxylase/17,20-Lyase Deficiency Caused by Phe93Cys Mutation in the CYP17 Gene

A. Di Giorgio, A. Savoia, M. R. Piemontese, 2002 .

Growth hormone and insulin-like growth factor 1 affect the severity of Graves’ disease

A. di Cerbo, F. Pezzuto, A. Di Cerbo, 2017, Endocrinology, diabetes & metabolism case reports.

Cyclooxygenase-dependent thyroid cell proliferation induced by immunoglobulins from patients with Graves' disease.

D. Corda, R. Di Paola, A. Di Cerbo, 1997, The Journal of clinical endocrinology and metabolism.

Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor.

D. Corda, R. Di Paola, L. Kohn, 1999, The Journal of clinical endocrinology and metabolism.

Signaling pathways involved in thyroid hyperfunction and growth in Graves' disease.

D. Corda, A. Di Cerbo, 1999, Biochimie.

Physiological concentrations of thyrotropin increase cytosolic calcium levels in primary cultures of human thyroid cells.

D. Corda, M. Falasca, M. Silletta, 1995, The Journal of clinical endocrinology and metabolism.

Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?

I. Chiodini, A. Liuzzi, M. Torlontano, 1996, Clinical endocrinology.